* Healthcare and consumer firms weigh on the index
* IOOF to buy NAB's wealth unit for $1.1 bln
* NZ bourse loses most in over a week
Aug 31 (Reuters) - Australian shares seesawed on Monday, as
investors remained cautious ahead of the central bank's cash
rate decision and second-quarter economic growth data expected
this week to gauge the impact of the COVID-19 pandemic
The S&P/ASX 200 index rose 0.2% to 6,083.60 by 0100
GMT, with gains capped by rising worries of an economic recovery
as the country reported a record daily rise in
Reserve Bank of Australia, set to meet on Tuesday, is
expected to hold the cash rate at its all-time low.
Meanwhile, GDP data for the second quarter on Wednesday is
likely to reflect the worst of the pandemic's impact.
Analysts at ANZ expect the economy to shrink 5.8% in the
June quarter from a year ago, while a Reuters poll forecasts the
contraction at 5.3%, compared with a growth of 1.4% in the March
The biggest drags on the main index were healthcare firms,
which fell as much as 0.9% to hit their lowest in about two
Heavyweight CSL Ltd slipped 0.8%, while ASX-listed
shares of Resmed Inc gave up 1.3%.
Gold stocks were among the gainers, rising as much
as 2.5%. Newcrest Mining gained 2.7% and Northern Star
Resources rose 3%.
National Australia Bank gained 0.8% after wealth
manager IOOF Holdings announced the acquisition of its
wealth management business for A$1.44 billion ($1.06 billion).
Across the Tasman Sea, New Zealand's benchmark S&P/NZX 50
index slipped 0.6%, or 72.94 points, to 12,020.58 as of
The bourse's website crashed for a fifth day in row on
Monday, after a series of cyber attacks last week hit the
bourse's ability to operate normally.
Financials and healthcare firms dragged down the index, with
NZ-listed shares of Westpac Banking Corp losing up to
1% and Fisher & Paykel Healthcare Corp shedding up to
(Reporting by Sameer Manekar in Bengaluru; Editing by Amy Caren